Nasus Pharma Ltd (NSRX) Total liabilities

Nasus Pharma Ltd (NSRX) total liabilities at each fiscal year-end, per SEC filings.

$2.2MFY2025

Fiscal year	Value	YoY
FY2025	$2.2M	—

Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.

Source: SEC XBRL filings · For reference only · Not investment advice

More NSRX financial trends

NSRX Revenue NSRX Net income NSRX Net margin NSRX Gross profit NSRX Gross margin NSRX Operating income NSRX Operating margin NSRX Operating cash flow NSRX Free cash flow NSRX Capital expenditures NSRX Return on equity NSRX Stock buybacks NSRX Dividends paid NSRX Total assets NSRX Shareholders’ equity NSRX overview →